"NovoSorb BTM is delivering outstanding clinical results with leading US, New Zealand and Australian surgeons now using the device regularly and several surgeons stating they no longer use biologic based scaffolds. "
"NovoSorb BTM is becoming the standard dermal scaffold of choice in some hospitals with the word spreading that it is outperforming the established biological based products."
- Looks like NovoSorb is quickly becoming the standard of care. Why would you use anything else?
"NovoSorb BTM is delivering outstanding clinical results with...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.34 |
Change
-0.020(0.85%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $2.34 | $2.37 | $2.32 | $2.004M | 857.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2441 | $2.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.34 | 19571 | 5 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.33 |
Change
-0.020 ( 1.24 %) |
||||
| Open | High | Low | Volume | ||
| $2.34 | $2.37 | $2.32 | 261156 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PNV (ASX) Chart |